Abstract
Neurons are highly polarized cells, often with very long processes, which can comprise up to 95% of the cytoplasm. This raises the issue of transporting and turnover of proteins transport. In addition to fast axonal transport, axonal translation has been proposed to be responsible for producing at least some axonal proteins. In multiple experimental models, local synthesis of several proteins has been demonstrated in axons, growth cones, and nerve terminals. Multiple lines of evidence are consistent with the existence of axonal rRNAs, mRNAs, tRNAs, and micro RNAs and micro RNA regulatory proteins (RISC complex). Multiple signalling pathways, including mTOR, may regulate axonal translation. The origin of axonal RNAs is often attributed to transport from the neuronal soma, but evidence supporting cell-to-cell transport from Schwann cells to axons as a source of at least some axonal RNAs is emerging. This intercellular transport will be discussed in the context of normal and regenerative conditions.
Keywords: Axon, local translation, miRNAs, mRNAs, mTOR, transcriptome, UTR, β-actin mRNA, Alpha- and beta-tubulin, energy-filtered transmission EM, periaxoplasmic ribosomal plaques, retinal ganglion cells, immuno-EM
Current Chemical Biology
Title: The Axonal Transcriptome: RNA Localization and Function
Volume: 5 Issue: 2
Author(s): Lucia Canclini, Alejandra Kun, Aldo Calliari, John A. Mercer, Jose R. Sotelo and Jose R. Sotelo-Silveira
Affiliation:
Keywords: Axon, local translation, miRNAs, mRNAs, mTOR, transcriptome, UTR, β-actin mRNA, Alpha- and beta-tubulin, energy-filtered transmission EM, periaxoplasmic ribosomal plaques, retinal ganglion cells, immuno-EM
Abstract: Neurons are highly polarized cells, often with very long processes, which can comprise up to 95% of the cytoplasm. This raises the issue of transporting and turnover of proteins transport. In addition to fast axonal transport, axonal translation has been proposed to be responsible for producing at least some axonal proteins. In multiple experimental models, local synthesis of several proteins has been demonstrated in axons, growth cones, and nerve terminals. Multiple lines of evidence are consistent with the existence of axonal rRNAs, mRNAs, tRNAs, and micro RNAs and micro RNA regulatory proteins (RISC complex). Multiple signalling pathways, including mTOR, may regulate axonal translation. The origin of axonal RNAs is often attributed to transport from the neuronal soma, but evidence supporting cell-to-cell transport from Schwann cells to axons as a source of at least some axonal RNAs is emerging. This intercellular transport will be discussed in the context of normal and regenerative conditions.
Export Options
About this article
Cite this article as:
Canclini Lucia, Kun Alejandra, Calliari Aldo, A. Mercer John, R. Sotelo Jose and R. Sotelo-Silveira Jose, The Axonal Transcriptome: RNA Localization and Function, Current Chemical Biology 2011; 5 (2) . https://dx.doi.org/10.2174/2212796811105020099
DOI https://dx.doi.org/10.2174/2212796811105020099 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Functional Correlation of Medicinal Chemistry and Entamoeba histolytica Treatment: An Emphasis on the Past, Present and Future Chemotherapy
Mini-Reviews in Medicinal Chemistry The Role of Aryl Hydrocarbon Receptor-Regulated Cytochrome P450 Enzymes in Glioma
Current Pharmaceutical Design SiRNA Nanotherapeutics _The Panacea of Diseases?
Current Gene Therapy The Therapeutic use of the Zonulin Inhibitor AT-1001 (Larazotide) for a Variety of Acute and Chronic Inflammatory Diseases
Current Medicinal Chemistry Diagnostic Value of the Early Heart-to-Mediastinum Count Ratio in Cardiac 123I-mIBG Imaging for Parkinson's Disease
Current Radiopharmaceuticals Immunophilin Dysfunction and Neuropathology
Current Medicinal Chemistry Sepsis: Links between Pathogen Sensing and Organ Damage
Current Pharmaceutical Design Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
Current Gene Therapy The Molecular Pathology of Huntingtons Disease (HD)
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
CNS & Neurological Disorders - Drug Targets Cardiac Metabolism in Myocardial Ischemia
Current Pharmaceutical Design Role of Transglutaminase-Catalyzed Reactions in the Post-Translational Modifications of Proteins Responsible for Immunological Disorders
Inflammation & Allergy - Drug Targets (Discontinued) Angelica Injection Improves Functional Recovery and Motoneuron Maintenance with Increased Expression of Brain Derived Neurotrophic Factor and Nerve Growth Factor
Current Neurovascular Research Peptidomimetic Inhibitors of Cathepsin K
Current Topics in Medicinal Chemistry Transposable Elements in Cancer and Other Human Diseases
Current Cancer Drug Targets Applications of Arterial Spin Labelling in Mild Cognitive Impairment, Alzheimers Disease and Other Forms of Dementia
Current Medical Imaging Laboratory Techniques for Human Viral Encephalitis Diagnosis
Infectious Disorders - Drug Targets Angiotensin II: Role in Skeletal Muscle Atrophy
Current Protein & Peptide Science Neuroprotection and Regeneration Strategies for Spinal Cord Repair
Current Pharmaceutical Design “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy